Get the Stockscreener App
3.8797
0.13%
-0.0303
Orasure Technologies Inc stock is traded at $3.8797, with a volume of 13,075.
It is down -0.13% in the last 24 hours and up +3.31% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$3.91
Open:
$3.94
24h Volume:
13,075
Relative Volume:
0.02
Market Cap:
$291.66M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
5.3885
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
-2.86%
1M Performance:
+3.31%
6M Performance:
-10.02%
1Y Performance:
-44.77%
1-Day Range:
$3.89
$3.94
1-Week Range:
$3.865
$4.06
52-Week Range:
$3.52
$8.04
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.89 | 291.66M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
588.81 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.45 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.13 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.98 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
329.55 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
OraSure Technologies (NASDAQ:OSUR) Stock Rating Upgraded by StockNews.com - MarketBeat
Microbiomes Market to Grow by USD 824.3 Million (2025-2029) with Rising Disease Prevalence Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - Yahoo Finance
OraSure Technologies, Inc. to Host Earnings Call - ACCESS Newswire
Exchange Traded Concepts LLC Invests $287,000 in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
Does Orasure Technologies Inc (OSUR) offer a good opportunity for investors? - SETE News
OraSure Technologies (NASDAQ:OSUR) Rating Lowered to "Hold" at StockNews.com - MarketBeat
Head-To-Head Contrast: PolyPid (NASDAQ:PYPD) versus OraSure Technologies (NASDAQ:OSUR) - Defense World
OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
New Strong Buy Stocks for January 27th - Yahoo Finance
Should Value Investors Buy OraSure Technologies (OSUR) Stock? - Yahoo Finance
JPMorgan Chase & Co. Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Point of Care Weekly Newsletter - substack.com
OraSure Technologies (NASDAQ:OSUR) Upgraded at StockNews.com - MarketBeat
OraSure Technologies (NASDAQ:OSUR) Upgraded to “Buy” at StockNews.com - Defense World
Global At-Home Testing Market to Reach USD 11,877.8 Million by 2035 with a CAGR of 4.8%, Driven by Rising Consumer Demand for Self-Diagnostic Tools | Future Market Insights, Inc. - GlobeNewswire Inc.
New Strong Buy Stocks for January 16th - Yahoo Finance
Barclays PLC Buys 126,503 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Barclays PLC - MarketBeat
Bethlehem manufacturer puts original headquarters up for sale - MSN
Over-the-Counter HIV Test Approved for Adolescents - Pulmonology Advisor
Retractable Technologies (NYSE:RVP) and OraSure Technologies (NASDAQ:OSUR) Critical Contrast - Defense World
NOWDiagnostics Faces Off With Biotech Rival In Trade Secrets Lawsuit - Arkansas Business
NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims - BioSpace
OraSure leaving original manufacturing site in Bethlehem - 69News WFMZ-TV
OraSure Technologies (NASDAQ:OSUR) Downgraded by StockNews.com to "Hold" - MarketBeat
OraSure Technologies’ Acquisition of Sherlock Biosciences - Global Legal Chronicle
OraSure to Present at the J.P Morgan Healthcare Conference - The Manila Times
OraSure Technologies, Inc.'s OraQuick HIV Self-Test Receives Approval for Use in Adolescents - Marketscreener.com
NEUBERGER BERMAN GROUP LLC Adjusts Holdings in OraSure Technologies Inc - GuruFocus.com
OraSure Technologies to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Are Investors Undervaluing OraSure Technologies (OSUR) Right Now? - Yahoo Finance
FDA Expands OraSure's HIV Self-Test Access to Teens Amid Rising Youth Diagnoses - StockTitan
CORRECTIONOraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewswire
OraQuick® HIV Self-Test Now Approved for Use in Adolescents - The Manila Times
OraSure Expands OraQuick HIV Self-Test Access to Teens 14+ Amid Rising Youth Cases - StockTitan
OSUR Stock Surges Over 5% Amid Market Activity - GuruFocus.com
Geode Capital Management LLC Purchases 32,929 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure in 2025: Changes, challenges and silver linings - 69News WFMZ-TV
OraSure Technologies (NASDAQ:OSUR) Upgraded by StockNews.com to Buy Rating - Defense World
Barclays PLC Raises Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Jane Street Group LLC - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Franklin Resources Inc. - Defense World
OraSure Technologies Completes Acquisition of Sherlock Biosciences, Inc. - Defense World
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):